The partnership with IVFAustralia, a part of the Virtus Health network, could potentially increase Cryoport's revenue and market presence. As Cryoport will be the exclusive supply chain solutions partner for IVFAustralia's global reproductive material shipments, this could lead to an increase in the company's client base and subsequently, its revenue. Furthermore, this partnership could enhance Cryoport's reputation in the industry, potentially attracting more clients in the future.